Welcome to our dedicated page for Nano-X Imaging news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging stock.
NANO-X IMAGING LTD reports news on an integrated medical imaging and healthcare services platform built around Nanox.ARC multisource digital tomosynthesis systems, AI and software solutions, cloud-based workflow tools, remote radiology access, health information technology and a marketplace model. Company updates commonly cover U.S. commercialization, distribution agreements, clinical collaborations and regulatory clearances tied to Nanox.ARC and related imaging capabilities.
Recurring financial and operating news also includes results from teleradiology services, imaging products and services, AI and software activity, and the completed addition of Nanox Health IT. The company frames its commercial activity around broader access to 3D imaging and preventive-care workflows across clinical settings.
Nanox Imaging (NNOX) has announced the appointment of three senior executives: Jim Dara as Chief Operating Officer, Ofir Koren as Chief Technology Officer, and Tamar Aharon as Chief Marketing Officer. These additions aim to drive the company's mission to democratize medical imaging. Nanox plans to begin deploying its Nanox.ARC technology in the latter half of 2021, pending regulatory approval. The leadership team is expected to provide diverse expertise, enhancing Nanox's capabilities in launching innovative medical imaging solutions.
NANO-X IMAGING LTD (NASDAQ: NNOX) announces participation in the Virtual 39th Annual J.P. Morgan Healthcare Conference from January 11-14, 2021. CEO Ran Poliakine will present on January 14 at 9:10 AM ET, available via live webcast. This event aims to showcase Nanox’s innovative medical imaging technology, designed to reduce costs and improve accessibility for healthcare services. Interested parties can access the webcast on Nanox’s website, with a replay available for 90 days post-event.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced an extension of its collaboration with USARAD Holdings to launch a cutting-edge radiology diagnostics service. This service combines over 300 radiologists and 20 FDA-cleared AI algorithms, targeting key healthcare players in the U.S. The initiative follows a prior agreement to deploy 3,000 Nanox.ARC medical imaging systems. With a focus on urgent conditions and routine reviews, the program aims to enhance healthcare quality and affordability while prioritizing urgent cases through advanced algorithms.
NANO-X IMAGING LTD (NNOX) unveiled its next-generation x-ray prototype, Nanox.ARC, at the RSNA Virtual Annual Meeting. The demonstration showcased various 2D and 3D imaging procedures. CEO Ran Poliakine emphasized that the technology could provide medical imaging access to two-thirds of the global population lacking it. The company has secured agreements for over 5,100 Nanox.ARC units and aims to commence deployments as early as mid-2021, pending regulatory approvals. This innovation is expected to enhance preventive healthcare through early disease detection.
NANO-X IMAGING LTD (NASDAQ: NNOX) will showcase its digital x-ray source tube and imaging applications at the RSNA 2020 virtual meeting on December 3, 2020, at 11:30 AM EST. An investor webinar will follow at 2:30 PM EST, featuring key insights from radiologists and a presentation by CEO Ran Poliakine. The event underscores Nanox's commitment to affordable medical imaging through innovative technology aimed at addressing unmet needs in the industry.
NANO-X IMAGING LTD (NASDAQ: NNOX) will showcase its innovative Nanox digital x-ray source tube and applications during the 2020 Radiology Society of North America Virtual Annual Meeting on December 3, 2020. The live demonstration is set for 11:00 AM ET, followed by an investor webinar at 2:00 PM ET featuring clinical applications presented by distinguished radiologists and a Q&A session with CEO Ran Poliakine. This novel technology aims to democratize and enhance the global medical imaging market.
Nano-X Imaging Ltd (NNOX) reported Q3 2020 results, indicating a net loss of $11.1 million, an increase from $1.9 million in Q3 2019. The company ended the quarter with $240 million in cash and no debt. Notably, Nano-X signed an agreement with SPI Medical to deploy 630 Nanox.ARC units across Mexico and Guatemala, increasing total contracts to 5,150 units in 13 countries. The company aims to achieve 15,000 system deployments by 2024. An IPO in August raised around $190 million to support these initiatives.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in three upcoming investor conferences. Key events include the Berenberg US CEO Conference on November 12, 2020, at 9:00 AM ET, the Jefferies Virtual London Healthcare Conference on November 17, 2020, at 5:35 AM ET, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 9:00 AM ET. Each event will have a live webcast available for registration. The company aims to leverage its innovative medical imaging technology for affordable healthcare solutions.
NANO-X IMAGING LTD has partnered with Ambra Health to enhance the exchange of medical imaging data across U.S. hospitals. This collaboration integrates Ambra’s cloud-based image management solution with the upcoming Nanox.ARC system, pending FDA approval. Ambra's platform, used in over 50 countries, manages over eight billion images, aiming to streamline workflows and improve patient communication. The partnership signifies a step towards more efficient medical data management, with intentions to provide seamless image transfer and enhance data privacy once authorized.
NANO-X IMAGING LTD (NASDAQ: NNOX) will release its third quarter 2020 financial results on November 9, 2020, prior to market opening. A conference call and webcast is scheduled for 8:30 AM ET on the same day, where management will discuss the results. Nanox is focused on innovative medical imaging technology, developing a digital X-ray source aimed at reducing imaging costs. The company seeks collaboration with leading healthcare entities to enhance accessibility to early detection imaging services. For more details, visit www.nanox.vision.